3SOF

CVM is loosing momentum, volume is low, and we had another red day on this stock. The $0.75 support was tested again, creating a small reaction there, but nothing serious.

It possible that the «green light» takes a bit more days to come, although we'll still be using the $0.69 stop level on this trade and wait developments.

Best regards,

Ramsburg.. This is a goodsupport area..67.-70.   I see why you used .69 but I am selling on a close below .67.. not just a print.. An announcement is inniment in my opinion from company on there most promising product.. Could go either way..

Madge

Quote from: madge20 on March 24, 2006, 01:13:44 PM
Ramsburg.. This is a goodsupport area..67.-70. I see why you used .69 but I am selling on a close below .67.. not just a print.. An announcement is inniment in my opinion from company on there most promising product.. Could go either way..

Madge

Your plan is also solid... Since $0.69 is also a strong technical reference, it may act as a good support, and your $0.67 level is a good spot... (I let you my updated chart in attach)

By some reason our stop at $0.69 didnt sell our position, but in order to follow the plan we sold immediately at $0.70.

PS: CVM will remain on our watch list.

CEL-SCI Files Patent for Prevention/Treatment of Bird (Avian) Flu
Tuesday , April 04, 2006 09:45 ET

VIENNA, Va., April 4, 2006 /PRNewswire-FirstCall via COMTEX/ -- CEL-SCI CORPORATION (Amex: CVM) announces that it has filed a provisional U.S. patent application covering its drug CEL-1000 for the prevention/treatment of bird flu and/or as an adjuvant to be included in a bird flu vaccine.

Geert Kersten, Chief Executive Officer of CEL-SCI said, "By filing this patent in the U.S., we are preserving our rights to file patents on this invention world-wide."

CEL-1000, when used as a single adjuvant (enhancer of a vaccine) or in combination with other adjuvants, potentiates Th1 (cellular) and innate (earliest stage) immune responses and protects animals from viral and parasitic challenge. CEL-1000 provides antigen-independent (i.e., non-disease specific) and broad-spectrum protection upon challenge with the disease causing agent(s), which is important against the bird flu virus since it exhibits a high mutation rate.

CEL-1000, is a patented defined amino acid sequence derived from the beta chain of human MHC-II, which itself is a modified version of a human immune- based protein known to bind to both human and mouse immune cells and appears to act by enhancing the host's protective immune response. It is a defined peptide, which binds to the CD4 and/or likely a related molecule LAG-3 on dendritic cells, macrophages and T cells, thereby promoting the release of cytokines responsible for activating a protective Th1 immune response (e.g., IL-12 and upon challenge IFN-gamma).

CEL-SCI Corporation is developing new immune system based treatments for cancer and infectious diseases. The Company has operations in Vienna, Virginia and Baltimore, Maryland.

When used in this report, the words "intends," "plans," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties, which could cause actual results to differ materially from those projected. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements, which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Ramsburg.. wanted you to know I held and Kudos to your screening and pick! I would have never owned had you not pointed out this company to me...

Sold today at an average of 1.60.. still monitoring for future.. let's see what happens tommorrow.

Madge

Quote from: madge20 on April 04, 2006, 05:31:44 PM
Ramsburg.. wanted you to know I held and Kudos to your screening and pick! I would have never owned had you not pointed out this company to me...

Sold today at an average of 1.60.. still monitoring for future.. let's see what happens tommorrow.

Madge

Madge and others,

I own a bunch of shares from 1.44 - What do you suggest I do with this one??? Let it run or sell tomorrow morning for a nice 20% gain...?

Thanks,
calven 

RAMS - Would love your thoughts on tomorrow's price action here...

Normally I would take profits with the recent 110% run but with so much volume behind it, I think it may want more....

Wow this would have been a nice one to have held onto. I didn't play it but I've been in similar situations as the 3Stocks crew is here -- cutting for a loss and then a week later it blasts off. Probably most of us have.

Madge, congrats on the gain! But what happened to "I am selling on a close below .67" It closed at .66 one day last week. You've made a good case against those who advise "never break your trading rules." Rules? We don't need no stinkin' rules! It's all about the Hamiltons baby

I don't think you should have sold though. I'd have held for a gap up tomorrow, in case it gapped like BDCO did on Monday. You probably had a 100% gain though - hard to resist taking those profits. Very nice $-)

Calven,
Looks like some daily support right now at 1.28. I am looking to reneter at 1.08-1.10 if it gets there... Definitely stop out if it closes below 1.05.. Long term its a toss up .. Don't know if there product will be " it"!

Quote from: madge20 on April 05, 2006, 11:53:14 AM
Calven,
Looks like some daily support right now at 1.28. I am looking to reneter at 1.08-1.10 if it gets there... Definitely stop out if it closes below 1.05.. Long term its a toss up .. Don't know if there product will be " it"!

Im in from 1.44 and now down on the position.... what do you guys make of today's price action? Will it retest highs next week?

cal 

I was surprised by the gap down. Madge, I was wrong and you were right. Nice exit! $-)

Yabadabado

At what price did you pikc up CVM ??

CVM seems to have formidable resistance at 1.50... Testing highs of the session. We'll see how this one shakes out.

1.690 - 1.70 gap fill